Bayer subsidiary Monsanto faces a $289 million jury verdict over its weedkiller Roundup, which has been linked to cancer. A jury in California found in favor of a retired school groundskeeper who used Roundup as a pesticide for decades. The dying man discovered tumors all over his body, and was diagnosed with in cancer in… Read More
Smith & Nephew Hip Implant Lawsuits Expand
R3 metal liners added to Birmingham Hip Resurfacing litigation A panel of federal judges overseeing hundreds of lawsuits against Smith & Nephew for their failed metal on metal hip devices is expanding the scope of the litigation. The United States Judicial Panel on Multidistrict litigation held that plaintiffs implanted with the recalled R3 metal liner… Read More
MRI risks detailed in new warning for Gadolinium
Gadolinium, a contrast agent used in MRI scans, is the target of a new health warning issued for patients and healthcare providers. The warnings are being added to the medication guide and patient materials for certain MRI, or magnetic resonance imaging tests. Top officials at Bayer, GE, Bracco Diagnostics and Guerbet signed off on the… Read More
Onglyza heart failure lawsuits expand
Onglyza diabetes drug lawsuits are growing in federal court, with the number of claims recently passing the 100 mark. The pharmaceutical legal team at Jones Ward is playing a leading role in these cases. Alex Davis, one of the firm’s partners, filed one of the first Onglyza heart failure lawsuits in federal court in 2016.… Read More
Smith & Nephew hip implant lawsuits survive preemption motion, advance toward trial
A federal judge overseeing more than 300 lawsuits against Smith & Nephew over the company’s recalled BHR hip implant system has ruled that numerous claims made by plaintiffs will advance toward trial. Hon. Catherine Blake, in a decision that followed eight months of briefing and arguments, held that claims including negligence, failure to warn, breach… Read More
Smith & Nephew hip implant lawsuits expand
The hip implant recall lawyers at Jones Ward are expanding the scope of a legal challenge to the Smith & Nephew BHR, targeting a configuration of the device that never gained FDA approval. Smith & Nephew faces approximately 300 individual lawsuits in federal court from patients who claim that the BHR failed and shed toxic… Read More
Onglyza heart failure MDL sent to Kentucky
Heart failure lawsuits tied to diabetes drugs Onglyza and Kombiglyze XR will be consolidated in Kentucky federal court, a panel of judges has decided. Ongylza and Kombiglyze XR are used by more than 100,00 Type 2 Diabetes patients in the U.S., and both drugs have been on the U.S. market since at least 2010. But it… Read More